Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
NXTM [NASD]
Nxstage Medical, Inc.
Index- P/E- EPS (ttm)-0.40 Insider Own1.80% Shs Outstand61.99M Perf Week5.55%
Market Cap1.13B Forward P/E- EPS next Y-0.32 Insider Trans17.72% Shs Float57.74M Perf Month2.35%
Income-24.30M PEG- EPS next Q-0.10 Inst Own97.50% Short Float6.35% Perf Quarter36.34%
Sales291.00M P/S3.89 EPS this Y-19.20% Inst Trans2.53% Short Ratio8.71 Perf Half Y28.93%
Book/sh3.01 P/B6.07 EPS next Y22.00% ROA-7.80% Target Price20.00 Perf Year88.74%
Cash/sh0.88 P/C20.74 EPS next 5Y20.00% ROE-12.70% 52W Range9.39 - 18.59 Perf YTD82.70%
Dividend- P/FCF- EPS past 5Y24.10% ROI-9.00% 52W High-2.69% Beta0.56
Dividend %- Quick Ratio1.90 Sales past 5Y15.40% Gross Margin38.80% 52W Low92.65% ATR0.74
Employees3200 Current Ratio2.90 Sales Q/Q12.60% Oper. Margin-7.70% RSI (14)61.91 Volatility4.97% 4.13%
OptionableYes Debt/Eq0.09 EPS Q/Q-37.50% Profit Margin-8.40% Rel Volume1.02 Prev Close18.27
ShortableYes LT Debt/Eq0.09 EarningsNov 06 BMO Payout- Avg Volume420.90K Price18.09
Recom1.90 SMA203.55% SMA5012.20% SMA20029.23% Volume428,443 Change-0.99%
May-03-13Reiterated Feltl & Co. Hold $11.50 → $12
Mar-01-13Reiterated Feltl & Co. Hold $13 → $11.50
Dec-04-12Downgrade Northland Securities Outperform → Market Perform
Sep-07-12Initiated Northland Securities Outperform $18
Feb-18-11Reiterated Rodman & Renshaw Mkt Underperform $15 → $18
Dec-03-10Initiated Jefferies Buy $27
Oct-14-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $15
Sep-15-10Initiated Feltl & Co. Buy $19
Jul-26-10Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
May-06-10Reiterated Rodman & Renshaw Mkt Outperform $11 → $14
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $11
Jun-05-09Upgrade William Blair Mkt Perform → Outperform
Aug-06-08Reiterated SMH Capital Buy $8 → $7
Aug-06-08Reiterated Canaccord Adams Hold $7 → $4.75
Jul-29-08Initiated SMH Capital Buy $8
May-14-08Reiterated JMP Securities Mkt Outperform $13 → $10
May-13-08Downgrade William Blair Outperform → Mkt Perform
May-13-08Downgrade Canaccord Adams Buy → Hold $12 → $7
Feb-13-08Reiterated SMH Capital Buy $18 → $13
Feb-13-08Reiterated JMP Securities Mkt Outperform $17 → $13
Dec-19-14 08:00AM  NxStage Founder and CEO Discusses Innovation in Healthcare at EY Boston Life Sciences Summit PR Newswire
Dec-18-14 09:00AM  NxStage to Present at the 33rd Annual J.P. Morgan Healthcare Conference PR Newswire
Nov-26-14 05:00PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
09:31AM  NxStage Medical (NXTM) Upgraded From Sell to Hold at TheStreet
Nov-21-14 05:30PM  NxStage Medical Unveils Streamline Express Dialyzer Zacks
Nov-18-14 08:45AM  NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set PR Newswire
Nov-14-14 01:04PM  NXSTAGE MEDICAL, INC. Financials EDGAR Online Financials
Nov-11-14 07:00AM  New Data Demonstrates Significant Advantage in Mortality, Hospitalization, and Patient Dropout with NxStage Home Hemodialysis when Compared with Peritoneal Dialysis PR Newswire
Nov-09-14 07:09PM  10-Q for NxStage Medical, Inc. Company Spotlight
Nov-07-14 04:17PM  NXSTAGE MEDICAL, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
08:00AM  NxStage Announces Fourth Quarter 2014 Investor Conference Schedule PR Newswire
Nov-06-14 07:43AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online +8.29%
07:31AM  NxStage Reports Record Third Quarter 2014 Financial Results And Raises Full-Year Revenue Guidance PR Newswire
07:07AM  Q3 2014 NxStage Medical Inc Earnings Release - Before Market Open CCBN
Nov-04-14 04:01PM  NxStage Announces Winner of First Annual Nurse Hero Campaign PR Newswire
Oct-30-14 08:00AM  Grand Opening of NxStage Kidney Care Oak Brook IL Center PR Newswire
Oct-29-14 05:09PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
Oct-24-14 08:00AM  NxStage Director of Public Policy Honored for Dedication to Patient Advocacy PR Newswire
Oct-08-14 09:57AM  NxStage Kidney Care Hosts Grand Opening Event at Florida Dialysis Center PR Newswire
Oct-07-14 08:00AM  NxStage® to Report Third Quarter 2014 Financial Results PR Newswire
Oct-01-14 05:01PM  NXSTAGE MEDICAL, INC. Files SEC form 10-Q/A, Quarterly Report EDGAR Online
Sep-16-14 08:00AM  NxStage Announces FDA Clearance of Single Needle Technology PR Newswire
Sep-10-14 08:00AM  NxStage Patients Participate in 257-Mile Tour DaVita Bike Ride PR Newswire
Aug-20-14 10:00AM  NxStage Kidney Care Opens New Orlando Florida Dialysis Center PR Newswire
Aug-12-14 08:00AM  Allan J. Collins, M.D., to join NxStage as Senior Medical Advisor PR Newswire
Aug-07-14 08:07AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online +5.98%
07:54AM  NXSTAGE MEDICAL, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:38AM  NxStage Reports Record Second Quarter 2014 Financial Results And Increases Full-Year Revenue Guidance PR Newswire
07:07AM  Q2 2014 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
Aug-01-14 08:00AM  NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference PR Newswire
Jul-17-14 08:01AM  NxStage® to Report Second Quarter 2014 Financial Results PR Newswire
Jul-16-14 10:09AM  NxStage Drives to Educate Kidney Patients PR Newswire
Jul-08-14 05:35PM  Mariel Therapeutics Acquires Stryker Assets Zacks
08:00AM  NxStage Kidney Care Hosts Grand Opening Celebration Of New State-Of-The-Art Dialysis Center In Jacksonville PR Newswire
Jul-03-14 11:31AM  NxStage Joins Patients in Celebrating Independence PR Newswire
08:15AM  NxStage Medical reiterated Outperform after CMS rule at William Blair at theflyonthewall.com
Jun-16-14 04:30PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial EDGAR Online
Jun-12-14 12:48PM  Avid Motorcyclist and NxStage Patient Reclaims His Life PR Newswire
May-28-14 05:11PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
May-19-14 08:00AM  Flexibility of Home Hemodialysis with NxStage System One Allows Patient to Achieve Life Milestone PR Newswire
May-15-14 08:17AM  NxStage to Present at the William Blair Growth Stock Conference PR Newswire
May-08-14 03:09PM  NxStage Medical's (NXTM) CEO Jeff Burbank on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha +8.84%
07:53AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
07:26AM  NxStage Medical sees Q2 revenue $70M-$71.5M, consensus $70.46M at theflyonthewall.com
07:26AM  NxStage Medical sees FY14 revenue to be in higher end of $283M-$288M at theflyonthewall.com
07:25AM  NxStage Medical reports Q1 EPS (9c), consensus (11c) at theflyonthewall.com
07:22AM  NxStage Reports Record First Quarter 2014 Financial Results And Exceeds Guidance PR Newswire
07:07AM  Q1 2014 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
Apr-15-14 08:15AM  NxStage Patient Enjoys Travel and Active Lifestyle PR Newswire -6.67%
Apr-08-14 08:00AM  NxStage® to Report First Quarter 2014 Financial Results PR Newswire
Mar-31-14 08:37AM  NxStage Wins 2014 American Red Cross Northeast Chapter Workplace Hero Award PR Newswire
Mar-20-14 08:00AM  NxStage Establishes First Annual National Home Hemodialysis Day PR Newswire
Mar-11-14 12:53PM  Despite skepticism, market technicals remain bullish at MarketWatch -5.80%
Mar-10-14 01:58PM  Stocks: Insiders Buy at Opko Health and Synageva BioPharma, Sell at EXCO Resources at Minyanville
Mar-03-14 04:16PM  NXSTAGE MEDICAL, INC. Files SEC form 10-K, Annual Report EDGAR Online
Feb-27-14 02:58PM  NxStage Medical's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
08:55AM  NxStage Medical, Inc. Discusses Q4 2013 Results (Webcast) at Seeking Alpha
07:45AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
07:31AM  NxStage Reports Record Fourth Quarter and Full-Year 2013 Financial Results PR Newswire
07:07AM  Q4 2013 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
Feb-24-14 08:00AM  Former NxStage Patient Celebrates Life Milestones PR Newswire
Feb-06-14 04:02PM  NxStage Medical Launches NxStage Plus One at 2014 Annual Dialysis Conference PR Newswire
Jan-21-14 08:24AM  NxStage® to Report Fourth Quarter and Full Year 2013 Financial Results PR Newswire
Jan-15-14 11:33PM  NxStage Medical CEO Presents at JPMorgan Healthcare Conference (Transcript) at Seeking Alpha
Jan-14-14 02:20PM  3 Stocks Spiking on Big Volume at TheStreet +10.52%
Jan-13-14 04:14PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
04:05PM  NxStage Increases Revenue Guidance for Fourth Quarter and Full-Year 2013 PR Newswire
Jan-08-14 12:33PM  NxStage Gaining Ground On Growing Adoption Of Home Hemodialysis at Seeking Alpha +5.84%
Jan-06-14 05:09PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events EDGAR Online
Dec-31-13 08:00AM  NxStage to Present at the 32nd Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-05-13 11:02AM  Fundamentally And Technically, Fresenius Wins Big Over DaVita at Seeking Alpha
Nov-26-13 10:23AM  Is It Time to Buy These 4 Dialysis Stocks? at Motley Fool
Nov-25-13 10:24AM  Moving Average Crossover: Great News for NxStage Medical, Inc. (NXTM)? Zacks
Nov-09-13 09:09AM  3 Horrendous Health-Care Stocks This Week at Motley Fool
Nov-08-13 06:02PM  Nasdaq stocks posting largest percentage decreases AP
12:17AM  NxStage Medical's CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
Nov-07-13 02:43PM  Why NxStage Medical Inc. Shares Slumped at Motley Fool -16.01%
09:00AM  NxStage Medical, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:55AM  NxStage Medical, Inc. Discusses Q3 2013 Results (Webcast) at Seeking Alpha
07:56AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
07:42AM  InPlay: Nxstage Medical misses by $0.02, reports revs in-line; guides Q4 EPS below consensus, revs below consensus Briefing.com
07:31AM  NxStage Reports Third Quarter 2013 Financial Results PR Newswire
NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Its primary product is the NxStage System One, a portable hemodialysis system used for the treatment of acute and chronic kidney failure, and fluid overload. The company operates in two segments, System One and In-Center. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment. This segment also sells extracorporeal disposable products, which are primarily used for in-center dialysis treatments for patients with end-stage renal disease (ESRD) in the home and critical care markets. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers; and needles for apheresis. NxStage Medical, Inc. markets its products through direct sales force and distributors to hospitals and dialysis centers in the United States and internationally. The company, formerly known as QB Medical, Inc., was founded in 1998 and is headquartered in Lawrence, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Turk Joseph E JrPresidentDec 15Option Exercise6.842,00013,680114,947Dec 16 04:48 PM
Turk Joseph E JrPresidentDec 15Sale17.452,00034,900112,947Dec 16 04:48 PM
Hershberger KevinChief Accounting OfficerDec 15Sale17.453,00052,35018,485Dec 16 04:26 PM
Hershberger KevinChief Accounting OfficerDec 12Option Exercise9.965,00049,80026,485Dec 16 04:26 PM
Hershberger KevinChief Accounting OfficerDec 12Sale17.045,00085,20021,485Dec 16 04:26 PM
Turk Joseph E JrPresidentDec 10Sale17.771,50026,655112,947Dec 11 05:03 PM
Burbank Jeffrey HCEODec 05Sale17.165,00085,800833,083Dec 08 05:41 PM
Brown Robert S.President, Kidney CareDec 03Option Exercise14.443004,33247,928Dec 04 07:55 PM
Brown Robert S.President, Kidney CareDec 03Sale17.483005,24447,628Dec 04 07:55 PM
Brown Robert S.President, Kidney CareDec 02Option Exercise14.4434,700501,06882,328Dec 02 08:02 PM
Brown Robert S.President, Kidney CareDec 02Sale17.4434,700605,16847,628Dec 02 08:02 PM
Swan Winifred LSVP and General CounselDec 01Option Exercise14.4416,667240,67135,855Dec 02 07:26 PM
Turk Joseph E JrPresidentDec 01Option Exercise14.4424,762357,563139,209Dec 02 07:37 PM
Turk Joseph E JrPresidentDec 01Sale17.0424,762421,944114,447Dec 02 07:37 PM
Swan Winifred LSVP and General CounselDec 01Sale17.0416,667284,00619,188Dec 02 07:26 PM
Turk Joseph E JrPresidentNov 25Option Exercise7.212,35016,941117,797Nov 25 07:38 PM
Turk Joseph E JrPresidentNov 25Sale17.593,35058,927114,447Nov 25 07:38 PM
Burbank Jeffrey HCEONov 24Option Exercise14.44120,0001,732,800936,481Nov 25 07:59 PM
Turk Joseph E JrPresidentNov 14Option Exercise14.4424,760357,534140,207Nov 17 05:40 PM
Swan Winifred LSVP and General CounselNov 14Option Exercise14.4416,667240,67136,355Nov 17 05:42 PM
Turk Joseph E JrPresidentNov 14Sale17.3724,760430,081115,447Nov 17 05:40 PM
Swan Winifred LSVP and General CounselNov 14Sale17.3717,167298,19119,188Nov 17 05:42 PM
Turk Joseph E JrPresidentNov 13Option Exercise9.964,80047,808120,247Nov 17 05:40 PM
Turk Joseph E JrPresidentNov 13Sale17.504,80084,000115,447Nov 17 05:40 PM
Hershberger KevinChief Accounting OfficerNov 12Option Exercise9.967,82477,92732,541Nov 12 06:58 PM
Turk Joseph E JrPresidentNov 12Sale16.581,50024,870115,447Nov 12 05:45 PM
Hershberger KevinChief Accounting OfficerNov 12Sale16.5811,056183,30821,485Nov 12 06:58 PM
Turk Joseph E JrPresidentNov 07Option Exercise14.4424,761357,549141,708Nov 12 05:45 PM
Turk Joseph E JrPresidentNov 07Sale16.2524,761402,366116,947Nov 12 05:45 PM
Swan Winifred LSVP and General CounselNov 05Option Exercise9.9612,000119,52031,688Nov 07 05:14 PM
Swan Winifred LSVP and General CounselNov 05Sale15.3012,000183,60019,688Nov 07 05:14 PM
Turk Joseph E JrPresidentNov 03Option Exercise14.445,71782,553122,664Nov 04 04:58 PM
Turk Joseph E JrPresidentNov 03Sale15.505,71788,614116,947Nov 04 04:58 PM
Brown Robert S.President, Kidney CareOct 23Option Exercise4.5443,470197,35491,098Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 23Sale14.5343,470631,61947,628Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 22Option Exercise4.541,9008,62649,528Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 22Sale14.501,90027,55047,628Oct 24 06:10 PM
Burbank Jeffrey HCEOOct 20Sale14.007,584106,176821,481Oct 22 04:26 PM
Turk Joseph E JrPresidentOct 20Sale14.001,50021,000117,947Oct 21 06:24 PM
Swan Winifred LSVP and General CounselOct 15Option Exercise6.842,96820,30123,156Oct 17 04:34 PM
Swan Winifred LSVP and General CounselOct 15Sale13.013,46845,11919,688Oct 17 04:34 PM
Turk Joseph E JrPresidentSep 24Option Exercise6.202,55015,813122,997Sep 26 05:22 PM
Turk Joseph E JrPresidentSep 24Sale13.343,55047,357119,447Sep 26 05:22 PM
Burbank Jeffrey HCEOSep 19Sale14.002,41633,824829,065Sep 22 05:14 PM
Turk Joseph E JrPresidentSep 19Sale14.001,30018,200120,447Sep 22 05:13 PM
Turk Joseph E JrPresidentSep 18Sale14.002002,800121,747Sep 22 05:13 PM
Hershberger KevinChief Accounting OfficerSep 10Sale13.5884311,44824,717Sep 10 05:05 PM
Turk Joseph E JrPresidentSep 08Sale14.001,50021,000121,947Sep 08 06:34 PM
Burbank Jeffrey HCEOSep 08Sale14.002,32232,508831,481Sep 08 06:29 PM
Turk Joseph E JrPresidentAug 27Option Exercise5.791,5508,973125,997Aug 28 05:19 PM
Turk Joseph E JrPresidentAug 27Sale13.062,55033,303123,447Aug 28 05:19 PM
Swan Winifred LSVP and General CounselAug 15Option Exercise6.842,00013,68022,188Aug 18 05:18 PM
Swan Winifred LSVP and General CounselAug 15Sale13.602,00027,20020,188Aug 18 05:18 PM
Swan Winifred LSVP and General CounselAug 14Sale13.615006,80520,188Aug 18 05:18 PM
Burbank Jeffrey HCEOAug 07Sale14.005,00070,000833,803Aug 08 05:03 PM
Turk Joseph E JrPresidentAug 07Sale14.001,50021,000124,447Aug 08 05:02 PM
Burbank Jeffrey HCEOJul 25Option Exercise4.97296,8461,473,998933,557Jul 29 05:05 PM
Turk Joseph E JrPresidentJul 24Option Exercise6.202,55015,813129,497Jul 28 04:54 PM
Turk Joseph E JrPresidentJul 24Sale13.503,55047,925125,947Jul 28 04:54 PM
Swan Winifred LSVP and General CounselJul 18Option Exercise6.842,00013,68022,688Jul 22 06:46 PM
Swan Winifred LSVP and General CounselJul 18Sale13.462,00026,92020,688Jul 22 06:46 PM
Swan Winifred LSVP and General CounselJul 17Sale13.505006,75020,688Jul 21 05:07 PM
Turk Joseph E JrPresidentJun 24Option Exercise5.982,95017,629130,897Jun 24 05:23 PM
Turk Joseph E JrPresidentJun 24Sale14.433,95056,999126,947Jun 24 05:23 PM
Burbank Jeffrey HCEOJun 20Sale14.005,00070,000636,711Jun 23 04:29 PM
Turk Joseph E JrPresidentJun 17Sale14.001,50021,000127,947Jun 18 04:51 PM
Hershberger KevinChief Accounting OfficerJun 10Sale13.8784311,69227,246Jun 12 07:07 PM
Swan Winifred LSVP and General CounselJun 09Option Exercise7.058,72861,50830,416Jun 11 05:38 PM
Swan Winifred LSVP and General CounselJun 09Sale14.009,228129,19221,188Jun 11 05:38 PM
Swan Winifred LSVP and General CounselJun 05Option Exercise9.967,50074,70029,188Jun 09 05:00 PM
Swan Winifred LSVP and General CounselJun 05Sale14.007,500105,00021,688Jun 09 05:00 PM
Turk Joseph E JrPresidentJun 05Sale14.001,50021,000129,447Jun 09 04:57 PM
Burbank Jeffrey HCEOJun 05Sale14.005,00070,000641,711Jun 09 04:55 PM
Turk Joseph E JrPresidentMay 29Option Exercise5.943,03518,014134,982Jun 02 06:45 PM
Turk Joseph E JrPresidentMay 29Sale13.604,03554,876130,947Jun 02 06:45 PM
Swan Winifred LSVP and General CounselMay 15Option Exercise4.269,62941,02631,317May 16 05:52 PM
Swan Winifred LSVP and General CounselMay 15Sale12.809,629123,25121,688May 16 05:52 PM
Swan Winifred LSVP and General CounselMay 14Sale13.045,00065,20021,688May 15 05:07 PM
Hershberger KevinChief Accounting OfficerMay 12Sale12.7884310,77428,089May 19 06:31 PM
Brown Robert S.President, Kidney CareMar 09Option Exercise0.003,056048,665Mar 11 09:29 PM
Hershberger KevinChief Accounting OfficerMar 09Option Exercise0.001,146029,367Mar 11 09:14 PM
Turk Joseph E JrPresidentMar 09Option Exercise0.003,0560132,974Mar 11 09:05 PM
Swan Winifred LSVP and General CounselMar 09Option Exercise0.003,056027,727Mar 11 08:57 PM
FUNARI ROBERT GDirectorMar 06Buy14.7210,150149,40810,150Mar 07 04:48 PM
MOORE CRAIG WDirectorMar 05Option Exercise3.3814,00047,32098,750Mar 07 04:46 PM
Swan Winifred LSVP and General CounselMar 04Option Exercise0.003,675026,064Mar 06 07:11 PM
Turk Joseph E JrPresidentMar 04Option Exercise0.003,6750131,311Mar 06 07:10 PM
Hershberger KevinChief Accounting OfficerMar 04Option Exercise0.001,378028,744Mar 06 07:09 PM
Burbank Jeffrey HCEOMar 04Option Exercise0.0010,1070644,454Mar 06 07:08 PM
Brown Robert S.President, Kidney CareMar 04Option Exercise0.003,675047,002Mar 06 07:08 PM
Giannini Daniel ADirectorJan 02Option Exercise3.3814,00047,32067,540Jan 03 05:05 PM